Safety and efficacy of brentuximab vedotin as a treatment for lymphoproliferative disorders in primary immunodeficiencies

• Thomas Pincez,
• Julie Bruneau,
• Laureline Berteloot,
• Eve Piekarski,
• Caroline Thomas,
• Ambroise Marçais,
• Amélie Trinquand,
• Martin Castelle,
• Nicolas Garcelon,
• Dominique Plantaz,
• Morgane Cheminant,
• Despina Moshous,
• Thierry Jo Molina,
• Olivier Hermine,
• Elizabeth Macintyre,
• Alain Fischer,
• Stéphane Blanche,
• Felipe Suarez,
• Bénédicte Neven

Affiliations

Thomas Pincez

Pediatric Hematology-Immunology and Rheumatology Department, Hôpital Necker-Enfants Malades, AP-HP, Paris

Julie Bruneau

Pathology Department, Hôpital Necker-Enfants Malades, AP-HP, Paris; Paris University, Paris; INSERM UMR 1163, Institut Imagine, Paris

Laureline Berteloot

Medical Imaging Department, Hôpital Necker-Enfants Malades, APHP, Paris

Eve Piekarski

Nuclear Medicine Department, Hôpital Bichat-Claude Bernard, AP-HP, Paris

Caroline Thomas

Pediatric Oncology-Hematology Department, Hôpital Enfant-Adolescent, CHU Nantes, Nantes

Ambroise Marçais

Paris University, Paris; INSERM UMR 1163, Institut Imagine, Paris; Department of Hematology, Hôpital Necker-Enfants Malades, AP-HP, Paris

Amélie Trinquand

Laboratory of Onco-Hematology, Hôpital Necker-Enfants Malades, AP-HP, Paris

Martin Castelle

Pediatric Hematology-Immunology and Rheumatology Department, Hôpital Necker-Enfants Malades, AP-HP, Paris

Nicolas Garcelon

Paris University, Paris; INSERM UMR 1163, Institut Imagine, Paris

Dominique Plantaz

Pediatric Hematology-Oncology Department, Grenoble University Hospital, Grenoble

Morgane Cheminant

Paris University, Paris; INSERM UMR 1163, Institut Imagine, Paris; Department of Hematology, Hôpital Necker-Enfants Malades, AP-HP, Paris

Despina Moshous

Pediatric Hematology-Immunology and Rheumatology Department, Hôpital Necker-Enfants Malades, AP-HP, Paris; Paris University, Paris; INSERM UMR 1163, Institut Imagine, Paris

Thierry Jo Molina

Pathology Department, Hôpital Necker-Enfants Malades, AP-HP, Paris; Paris University, Paris

Olivier Hermine

Paris University, Paris; INSERM UMR 1163, Institut Imagine, Paris; Department of Hematology, Hôpital Necker-Enfants Malades, AP-HP, Paris

Elizabeth Macintyre

Paris University, Paris; Laboratory of Onco-Hematology, Hôpital Necker-Enfants Malades, AP-HP, Paris; INSERM UMR 1151, Institut Necker-Enfants Malades, Paris

Alain Fischer

Pediatric Hematology-Immunology and Rheumatology Department, Hôpital Necker-Enfants Malades, AP-HP, Paris; Paris University, Paris; INSERM UMR 1163, Institut Imagine, Paris; Collège de France, Paris, France

Stéphane Blanche

Pediatric Hematology-Immunology and Rheumatology Department, Hôpital Necker-Enfants Malades, AP-HP, Paris; Paris University, Paris; INSERM UMR 1163, Institut Imagine, Paris

Felipe Suarez

Paris University, Paris; INSERM UMR 1163, Institut Imagine, Paris; Department of Hematology, Hôpital Necker-Enfants Malades, AP-HP, Paris

Bénédicte Neven

Pediatric Hematology-Immunology and Rheumatology Department, Hôpital Necker-Enfants Malades, AP-HP, Paris; Paris University, Paris; INSERM UMR 1163, Institut Imagine, Paris